Antiverse

Antiverse is a biotechnology company that has developed a computational antibody drug discovery platform. Antiverse combines machine learning and phage display technology to simulate antibody-antigen interactions. The current version of the platform uses sequencing and artificial intelligence to select diverse antibody candidates for any given target. This technology was developed to discover biologics for difficult-to-drug targets associated with cancer, heart disease, and lung disease.